Wassil Jim sold $96K of PCVX
Wassil Jim (CHIEF OPERATING OFFICER) sold 1,949 shares of Vaxcyte, Inc. (PCVX) at $49.40 on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure can modestly influence short-term sentiment, but it is not a fundamental update by itself.
Market read
Traders may monitor for follow-on insider activity, but this specific filing is unlikely to drive a durable repricing without additional catalysts.
What to watch
The article provides only the sale size and plan status, not whether other insiders/funds changed positions around the same time.
Background
SEC Form 4 reports insider transactions; 10b5-1 plans are pre-arranged to reduce timing-based trading concerns.
Ticker impact
Vaxcyte COO Wassil Jim sold $96.3K of PCVX shares via an open-market transaction under a pre-arranged 10b5-1 plan.
Limited immediate impact expected; any reaction is likely sentiment-driven and short-lived.
The filing is a routine officer sale under a pre-arranged 10b5-1 plan, with no accompanying operational/financial catalyst in the article.
Market effects
Minimal; this is company-specific insider disclosure with no stated sector/regulatory catalyst.
None.
None.
Counterpoint
Because the sale is under a 10b5-1 plan, the market may overreact; the disclosure may not reflect new bearish information.
Key entities
- issuerVaxcyte, Inc.
Subject of the insider transaction disclosure (PCVX).
- officerWassil Jim
Chief Operating Officer who sold 1,949 shares on June 1 under a 10b5-1 plan.
